ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Ra Pharma files $100M round as Soliris rival clears phase 2 trial
December 27, 2018Armed with a phase 2 win for its lead drug zilucoplan in rare disease myasthenia gravis (MG), Ra Pharma has pressed the button on a public funding round that it hopes could raise up to $115 million...... -
FDA Approves New Treatment for Paroxysmal Nocturnal Hemoglobinuria
December 27, 2018The U.S. Food and Drug Administration (FDA) approved Ultomiris (ravulizumab) injection for the treatment of adult patients with paroxysmal nocturnal hemoglobinuria (PNH), a rare and life-threatening blood disease..... -
FDA Approves Ultomiris (ravulizumab-cwvz) for Adults with Paroxysmal Nocturnal Hemoglobinuria (PNH)
December 26, 2018Alexion Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Ultomiris (ravulizumab-cwvz).....
Pharma Sources Insight January 2025
